[68Ga]PSMA-11 PET findings in intermediate/high risk prostate cancer patients at staging

被引：0
|
作者：
Scarale, A. [1 ]
Capitanio, S. [1 ]
Franchini, A. [2 ]
Potami, M. A. [1 ]
Longoni, M. [1 ]
Tappero, S. [1 ]
Gay, E. [1 ]
Cabrini, G. [1 ]
Milella, M. [1 ]
Dell'Oglio, P. [1 ]
Galfano, A. [1 ]
Bocciardi, A. M. [1 ]
Rossetti, C. [1 ]
机构：
[1] IASST Grande Osped Metropolitano Niguarda, Milan, Italy
[2] Univ Milano Bicocca, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-137
引用
收藏
页码：S455 / S455
页数：1
相关论文
共 50 条
  • [41] Comparison of Multiparametric MRI, [68Ga]Ga-PSMA-11 PET-CT, and Clinical Nomograms for Primary T and N Staging of Intermediate-to-High-Risk Prostate Cancer
    Tayara, Omar Marek
    Pelka, Kacper
    Kunikowska, Jolanta
    Malewski, Wojciech
    Sklinda, Katarzyna
    Kamecki, Hubert
    Poletajew, Slawomir
    Kryst, Piotr
    Nyk, Lukasz
    CANCERS, 2023, 15 (24)
  • [42] FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging
    Masters, Shane C.
    Hofting, Alex
    Gorovets, Alex
    Marzella, Libero
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (01): : 27 - 28
  • [43] [68Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer
    Clore, Jessica
    Scott, Peter J. H.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024,
  • [44] Staging with [68Ga]Ga-PSMA-11 PET/CT in patients with intermediate and high-risk prostate cancer prior surgery. Is there any association between semiquantitative parameters and biochemical recurrence?
    Rosales, J.
    Bastidas, J.
    Bronte, A.
    Betech-Antar, V.
    Minguez, F.
    Romera, M.
    Pareja, F.
    Guillen, E.
    Menendez-Sanchez, S.
    Beorlegui, C.
    Arbizu, J.
    Gracia, J. Perez
    Rodriguez-Fraile, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S230 - S230
  • [45] MR PET scan with 68GA PSMA in prostate cancer
    Lo, R.
    Lo, C.
    Chan, J.
    Cheung, W.
    Lo, G.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 84 - 85
  • [46] MR PET scan with 68Ga PSMA in prostate cancer
    Lo, R. K.
    Lo, C. S.
    Chan, J. K.
    Cheung, W. S.
    Lo, G. G.
    BJU INTERNATIONAL, 2017, 119 : 7 - 7
  • [47] Predictor of 68Ga PSMA PET/CT positivity in patients with prostate cancer
    Soydal, Cigdem
    Urun, Yuksel
    Suer, Evren
    Nak, Demet
    Ozkan, Elgin
    Kucuk, Nuriye O.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (02): : 226 - 230
  • [48] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer
    Tulsyan, Shruti
    Das, Chandan J.
    Tripathi, Madhavi
    Seth, Amlesh
    Kumar, Rajeev
    Bal, Chandrasekhar
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1094 - 1102
  • [49] 68Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate- and High-Risk Prostate Cancer
    Kuten, Jonathan
    Mabjeesh, Nicola J.
    Lerman, Hedva
    Levine, Charles
    Barnes, Sophie
    Even-Sapir, Einat
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2019, 21 (02): : 100 - 104
  • [50] Association of [68Ga]Ga-PSMA-11 PET/CT Metrics with PSA Persistence Following Radical Prostatectomy in Patients with Intermediate- and High-Risk Prostate Cancer
    Rosales, Juan J.
    Betech-Antar, Vicky
    Minguez, Fernando
    Guillen, Edgar F.
    Prieto, Elena
    Quincoces, Gemma
    Beorlegui, Carmen
    de la Maza, Maria Dolores Fenor
    Diez-Caballero, Fernando
    Minana, Bernardino
    Perez-Gracia, Jose Luis
    Rodriguez-Fraile, Macarena
    DIAGNOSTICS, 2025, 15 (03)
12345